StockDriftsStockDriftsTop 20 B Group INC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| ADMA | ADMA BIOLOGICS INC | 21.43% | 3.21M | $28.9M | +30.52%(+750.00K) | $17.32(-48.33%) | 2026-03-31 | |
| PALI | PALISADE BIO INC | 14.81% | 11.41M | $20.0M | +153.65%(+6.91M) | $1.87(+12.03%) | 2026-03-31 | |
| PRAX | PRAXIS PRECISION MEDICINES I | 7.94% | 33.2K | $10.7M | +0.00%(+0) | $56.11(+467.67%) | 2026-03-31 | |
| CLLS | CELLECTIS S A | 7.71% | 3.28M | $10.4M | +0.00%(+0) | $1.94(+70.26%) | 2026-03-31 | |
| ZLAB | ZAI LAB LTD | 6.28% | 450.6K | $8.5M | +12.66%(+50.65K) | $24.39(-21.59%) | 2026-03-31 | |
| TSHA | TAYSHA GENE THERAPIES INC | 5.97% | 1.80M | $8.0M | +0.00%(+0) | $1.90(+244.46%) | 2026-03-31 | |
| NRXP | NRX PHARMACEUTICALS INC | 4.74% | 3.00M | $6.4M | new | $3.28(+17.99%) | 2026-03-31 | |
| GPCR | STRUCTURE THERAPEUTICS INC | 4.56% | 127.5K | $6.1M | +41.67%(+37.50K) | $51.75(+3.29%) | 2026-03-31 | |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 3.9% | 1.50M | $5.3M | +0.00%(+0) | $7.37(-41.51%) | 2026-03-31 | |
| SYRE | SPYRE THERAPEUTICS INC | 3.74% | 100.0K | $5.0M | +0.00%(+0) | $21.93(+294.98%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +12.06% | +40.72% |
| Top 20 Holdings Unweighted | +60.79% | +315.73% |
Sign up free to track B Group INC, compare funds side by side, and get alerts the moment positions change.